These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24947993)

  • 1. Barriers to access for Canadians who use cannabis for therapeutic purposes.
    Belle-Isle L; Walsh Z; Callaway R; Lucas P; Capler R; Kay R; Holtzman S
    Int J Drug Policy; 2014 Jul; 25(4):691-9. PubMed ID: 24947993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
    Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
    Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada.
    Capler R; Walsh Z; Crosby K; Belle-Isle L; Holtzman S; Lucas P; Callaway R
    Int J Drug Policy; 2017 Sep; 47():1-8. PubMed ID: 28667878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
    Fischer B; Kuganesan S; Room R
    Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to access to medical cannabis for Canadians living with HIV/AIDS.
    Belle-Isle L; Hathaway A
    AIDS Care; 2007 Apr; 19(4):500-6. PubMed ID: 17453590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental Health and Medical Cannabis Use among Youth and Young Adults in Canada.
    Wadsworth E; Leos-Toro C; Hammond D
    Subst Use Misuse; 2020; 55(4):582-589. PubMed ID: 31747851
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabis education needs assessment among Canadian physicians-in-training.
    St Pierre M; Matthews L; Walsh Z
    Complement Ther Med; 2020 Mar; 49():102328. PubMed ID: 32147035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients.
    Lucas P; Walsh Z
    Int J Drug Policy; 2017 Apr; 42():30-35. PubMed ID: 28189912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis in medicine: a national educational needs assessment among Canadian physicians.
    Ziemianski D; Capler R; Tekanoff R; Lacasse A; Luconi F; Ware MA
    BMC Med Educ; 2015 Mar; 15():52. PubMed ID: 25888752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries.
    Hakkarainen P; Frank VA; Barratt MJ; Dahl HV; Decorte T; Karjalainen K; Lenton S; Potter G; Werse B
    Int J Drug Policy; 2015 Mar; 26(3):250-6. PubMed ID: 25123694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis for therapeutic purposes and public health and safety: a systematic and critical review.
    Sznitman SR; Zolotov Y
    Int J Drug Policy; 2015 Jan; 26(1):20-9. PubMed ID: 25304050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived support for medical cannabis use among approved medical cannabis users in Canada.
    Leos-Toro C; Shiplo S; Hammond D
    Drug Alcohol Rev; 2018 Jul; 37(5):627-636. PubMed ID: 29873132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage.
    Sznitman SR; Lewis N
    Int J Drug Policy; 2015 May; 26(5):446-52. PubMed ID: 25661483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.
    Rotermann M; Pagé MM
    Health Rep; 2018 Jul; 29(7):3-13. PubMed ID: 30020531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study.
    Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
    Epilepsy Behav; 2020 Oct; 111():107120. PubMed ID: 32570201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing barriers associated with delivering health care services to migratory agricultural workers.
    Schmalzried HD; Fallon LF
    Rural Remote Health; 2012; 12():2088. PubMed ID: 22827833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accommodating the medical use of marijuana: surveying the differing legal approaches in Australia, the United States and Canada.
    Bogdanoski T
    J Law Med; 2010 Feb; 17(4):508-31. PubMed ID: 20329455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing expertise: Canadian community-based medical cannabis dispensaries as embodied health movement organisations.
    Penn RA
    Int J Drug Policy; 2014 May; 25(3):372-7. PubMed ID: 24439711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada.
    Capler NR; Balneaves LG; Buxton JA; Kerr T
    J Cannabis Res; 2023 Jun; 5(1):18. PubMed ID: 37291647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.